Executive Management And Bonus Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Immunoclin Corp – Executive Management and Bonus Agreement (March 4th, 2014)

THIS AGREEMENT (the "Agreement") effective as of this Twenty-third (23rd) day of January 2014 (the Effective Date), entered into between Pharma Investing News, Inc. a Nevada Corporation, with its principal offices located at 9107 Wilshire Blvd, Suite 450, Beverly Hills, CA 90210 (the Company or PINV) and Dr. Khadija Benlhassan of Paris, France and/or her assigns (the Executive) (together, the Company and the Executive may be referred to herein as the "parties", or each individually as a "party").

Immunoclin Corp – Executive Management and Bonus Agreement (December 20th, 2013)

THIS AGREEMENT (the "Agreement") effective as of this thirteenth (13th) day of December 2013 (the Effective Date), entered into between Pharma Investing News, Inc. a Nevada Corporation, with its principal offices located at 9107 Wilshire Blvd, Suite 450, Beverly Hills, CA 90210 (the Company or PINV) and CSJ Group LLC or its Assigns (owned 100% by Chad S. Johnson, Esq. of Washington, DC) (herein, the Executive) (together, the Company and the Executive may be referred to herein as the "parties", or each individually as a "party").

Immunoclin Corp – Executive Management and Bonus Agreement (December 20th, 2013)

THIS AGREEMENT (the "Agreement") effective as of this thirteenth (13th) day of December 2013 (the Effective Date), entered into between Pharma Investing News, Inc. a Nevada Corporation, with its principal offices located at 9107 Wilshire Blvd, Suite 450, Beverly Hills, CA 90210 (the Company or PINV) and James Scott Munro of Vancouver, BC, Canada or his assigns (the Executive) (together, the Company and the Executive may be referred to herein as the "parties", or each individually as a "party").

Immunoclin Corp – Executive Management and Bonus Agreement (December 20th, 2013)

THIS AGREEMENT (the "Agreement") effective as of this thirteenth (13th) day of December 2013 (the Effective Date), entered into between Pharma Investing News, Inc. a Nevada Corporation, with its principal offices located at 9107 Wilshire Blvd, Suite 450, Beverly Hills, CA 90210 (the Company or PINV) and Dr. Dorothy H Bray of the United Kingdom (the Executive) (together, the Company and the Executive may be referred to herein as the "parties", or each individually as a "party").